Dr. Kelvin Chan is a medical oncologist at the Sunnybrook Odette Cancer Centre, a professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and head and neck oncology. He has completed his PhD in biostatistics (focusing on statistical methods in health economic evaluations) at the Dalla Lana School of Public Health, University of Toronto.
As a clinical epidemiologist and biostatistician, Dr. Chan’s research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the co-director at the Canadian Centre for Applied Research in Cancer Control (ARCC).
Professionally, Dr. Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including membership at the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drug (CED) and the interim chair for the Ontario Steering Committee of Cancer Drugs (OSCCD), Ontario MOHLTC and Ontario Health (Cancer Care Ontario). He is also the clinical lead for the Provincial Drug Reimbursement Programs (PDRP) at Ontario Health (Cancer Care Ontario).
